RCE.AX

Recce Pharmaceuticals Ltd RCE.AX

RCE.AX
Recce Pharmaceuticals Ltd ATH.AX
Alterity Therapeutics Limited IMU.AX
Imugene Limited EZZ.AX
EZZ Life Science Holdings Limited ALA.AX
Arovella Therapeutics Limited SPL.AX
Starpharma Holdings Limited ACW.AX
Actinogen Medical Limited PCK.AX
PainChek Limited PAR.AX
Paradigm Biopharmaceuticals Limited LDX.AX
Lumos Diagnostics Holdings Limited

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode RCE.AX ATH.AX IMU.AX EZZ.AX ALA.AX SPL.AX ACW.AX PCK.AX PAR.AX LDX.AX
6M 41.38 % 71.43 % -54.66 % 68.35 % 17.95 % 170.83 % 0.00 % 84.38 % 37.93 % 620.00 %
YTD -16.33 % 33.33 % -72.18 % -10.74 % -45.88 % 136.36 % 15.38 % 110.71 % 0.00 % 373.68 %
1Y -26.79 % 300.00 % -77.84 % -35.75 % -52.82 % 179.57 % 15.38 % 87.24 % 50.94 % 300.00 %
3Y -37.26 % -7.69 % -93.60 % 772.13 % 217.24 % -59.69 % -72.46 % 99.72 % -70.37 % 268.91 %
5Y -64.04 % -73.33 % -80.93 % 129.31 % 124.39 % -82.43 % 31.94 % -42.75 % -86.01 % -84.07 %
10Y 38.03 % -90.00 % 22.00 % 129.31 % -83.37 % -63.89 % -45.23 % 90.82 % 41.39 % -84.07 %
From the beginning 38.03 % -97.60 % -99.55 % 129.31 % -97.20 % -69.41 % -95.44 % -80.83 % 14.67 % -84.07 %

Dividend

EZZ Life Science Holdings Limited